Skip to content

The effects of DHA/EPA supplementation on atopic dermatitis disease in adult Japanese

The effects of DHA/EPA supplementation on atopic dermatitis disease in adult Japanese

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs031220016
Enrollment
5
Registered
2022-04-12
Start date
2022-04-12
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic dermatitis

Interventions

DHA/EPA-containing foods: 1 bottle / day, 12weeks

Sponsors

Tsuyoshi Takara
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Japanese adults 2. Men or women 3. Subjects aged 20 years old or more 4. Subjects who have been diagnosed with atopic dermatitis 5. Subjects who are judged as eligible to participate in the study by the physician

Exclusion criteria

Exclusion criteria: 1. Subjectss with moderate or severe atopic dermatitis (skin rash with severe inflammation*) *Lesions with erythema, papules, erosions, infiltrates, lichenification, etc. 2. Subjects have allergy to milk 3. Subjects who are aspirin hypersensitivity or who are regular users of drugs containing aspirin 4. Subjects who consume bluefish such as sardines, mackerel, and saury at least 4 days per week. 5. Subjects who are pregnant, breast-feeding, and planning to become pregnant 6. Subjects who suffering from COVID-19 7. Subjects who have been enrolled in other clinical trials within the last 28 days before the agreement to participate in this trial or plan to participate another trial during this trial 8. Subjects who are judged as ineligible to participate in the study by the physician

Design outcomes

Primary

MeasureTime frame
Clinical findings VAS (Itch of skin) Skindex-16 Plasma total lipid fatty acid fraction Serum TARC

Contacts

Public ContactSuzuki Naoko

ORTHOMEDICO Inc.

nao@orthomedico.jp+81-3-3813-5106

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026